Adverse drug reactions with fluoroquinolones

Therapie

Volumn 51, Issue 4, 1996, Pages 414-416

  Royer, R J ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Drug surveillance; European Community; Fluoroquinolones; Spontaneous notification

Indexed keywords

CIPROFLOXACIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADVERSE DRUG REACTION; ANAPHYLAXIS; ARTHRITIS; CONFERENCE PAPER; DRUG SURVEILLANCE PROGRAM; KIDNEY FAILURE; PHOTOSENSITIVITY; PRIORITY JOURNAL; RASH; SHOCK; TENDON RUPTURE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; FRANCE; GREAT BRITAIN; HUMANS;

EID: 0029738957     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. Bonnes pratiques de Pharmacovigilance. Therapie 1995; 50: 547-555
2. Wilton LV, Pearce GL, Mann RD. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. Br J Clin Pharmacol (in press).